Pharmaceutical News

RSS

Low dose colchicine significantly reduces risk of cardiovascular death

An Australian-Dutch trial led by Perth GenesisCare cardiologists, Professor Peter Thompson and Dr Mark Nidorf,

1 Sep 2020

14 existing drugs identified as SARS-CoV-2 main protease inhibitors

Now, a new study published on the preprint server bioRxiv in August 2020 reports on the identification of 14 compounds that can inhibit the key viral enzyme called the Main Protease (MPro) at micromolar concentrations.

1 Sep 2020

Researchers propose new reforms to improve transparency of drug authorizations

On March 28, the Food and Drug Administration (FDA) exercised its Emergency Use Authorization (EUA) authority to allow the use of hydroxychloroquine for the treatment of COVID-19. On June 15, after a number of studies failed to find positive effects, the agency revoked this authorization.

1 Sep 2020

New study weighs effectiveness of three anticonvulsant drugs to treat deadly seizures

Three anticonvulsant drugs commonly used to stop prolonged, potentially deadly seizures each work equally well, according to a national study led by physicians at UT Southwestern.

31 Aug 2020

Blood pressure medication could be an effective tool for reducing cardiovascular risk

Blood pressure medication can prevent heart attacks and strokes - even in people with normal blood pressure. That's the finding of late breaking research presented in a Hot Line session today at ESC Congress 2020.

31 Aug 2020

Antihypertensive drugs are not linked to cancer, shows study

There is no evidence that blood pressure lowering drugs increase the risk of cancer, according to the most extensive study conducted on the topic. The late breaking research is presented today at ESC Congress 2020.

31 Aug 2020

$Empagliflozin reduces risk of death in patients with heart failure and reduced ejection fraction$

Empagliflozin reduces risk of death in patients with heart failure and reduced ejection fraction

Empagliflozin reduces the risk of cardiovascular death or hospitalization for heart failure in patients with heart failure and a reduced ejection fraction.

31 Aug 2020

WHO advises healthcare professionals to ensure correct administration of chlorhexidine

WHO has been made aware of multiple, recent reports of eye injury, including blindness, with the use of chlorhexidine gluconate 7.1%, in nine countries in sub Saharan Africa.

31 Aug 2020

Trimetazidine does not improve outcomes in patients with chronic or acute coronary syndromes

Trimetazidine administered after successful percutaneous coronary intervention (PCI) does not improve outcomes in patients with chronic or acute coronary syndromes, according to results of the ATPCI trial presented in a Hot Line session today at ESC Congress 2020.

31 Aug 2020

Study: Preventive medications reduce risk of heart attacks in diabetic patients

Dramatic reductions in the risk of heart attacks in patients with diabetes coincides with major increases in the use of preventive medications. That's the finding of late breaking research presented today at ESC Congress 2020.

31 Aug 2020

FDA announces public meeting to discuss development and licensure of COVID-19 vaccines

The U.S. Food and Drug Administration announced that a public meeting of the Vaccines and Related Biological Products Advisory Committee will be held on CutOct. 22, 2020, to discuss the general matter of the development, authorization, and/or licensure of vaccines indicated to prevent COVID-19.

29 Aug 2020

Race to produce COVID vaccines should not leave the poor left behind, says expert

Race to produce vaccines against COVID-19 must ensure that the poor are not left behind, says Crispin Maslog. A mad race to produce a vaccine against COVID-19 has begun with the world's superpowers leading the pack.

29 Aug 2020

New algorithm can help spot illicit online pharmacies

Consumers are expected to spend more than $100 billion at online pharmacies in the next few years, but not all of these businesses are legitimate.

28 Aug 2020

Interventions can successfully reduce the rate of inappropriate antibiotic prescriptions

Two different interventions both worked to significantly reduce the rate of inappropriate antibiotic prescriptions made by physicians in a telemedicine practice, a new study led by Children's National Hospital researchers shows.

27 Aug 2020

New approach to combination drug design could be applied to disease therapies beyond diabetes

Biomedical engineers at Duke University have shown that the efficacy of a two-pronged type 2 diabetes treatment increases when the drugs are linked by a heat-sensitive tether rather than simply concurrently administered.

27 Aug 2020

Trump again claims he’s bringing down drug prices, but details of how are skimpy

President Donald Trump has long considered lowering the high cost of prescription drugs to be one of his signature issues, and it is likely to be a talking point he relies on throughout the upcoming campaign.

26 Aug 2020

Higher dosage of opioids for outpatient knee surgery is linked to increased risk of overdose death

A new study published in BMJ Open found that opioid prescription rates for outpatient knee surgery vary widely across the country, but the strength of the average prescription in the United States is at a level that has been linked to an increased risk of overdose death.

26 Aug 2020

Study: COVID-19 vaccine should be at least 80% effective to prevent ongoing pandemic

The American Journal of Preventive Medicine, published by Elsevier, is committed to publishing the most robust, evidence-based research and commentary on COVID-19 as they unfold to keep readers up to date and aware of issues relevant to community and individual health during this continually evolving global outbreak.

26 Aug 2020

Antibiotics used for treating COVID-19 patients may result in increased resistance to drugs' benefits

The use of antibiotics in people with COVID-19 could result in increased resistance to the drugs' benefits among the wider population, a new study suggests.

25 Aug 2020

Delivering split immunotoxins separately to cancer cells can reduce life-threatening side effects

Splitting one type of cancer drug in half and delivering the pieces separately to cancer cells could reduce life-threatening side effects and protect healthy, non-cancerous cells, a new study suggests.

25 Aug 2020

Pharmaceutical News

Low dose colchicine significantly reduces risk of cardiovascular death

14 existing drugs identified as SARS-CoV-2 main protease inhibitors

Researchers propose new reforms to improve transparency of drug authorizations

New study weighs effectiveness of three anticonvulsant drugs to treat deadly seizures

Blood pressure medication could be an effective tool for reducing cardiovascular risk

Antihypertensive drugs are not linked to cancer, shows study

Empagliflozin reduces risk of death in patients with heart failure and reduced ejection fraction

WHO advises healthcare professionals to ensure correct administration of chlorhexidine

Trimetazidine does not improve outcomes in patients with chronic or acute coronary syndromes

Study: Preventive medications reduce risk of heart attacks in diabetic patients

FDA announces public meeting to discuss development and licensure of COVID-19 vaccines

Race to produce COVID vaccines should not leave the poor left behind, says expert

New algorithm can help spot illicit online pharmacies

Interventions can successfully reduce the rate of inappropriate antibiotic prescriptions

New approach to combination drug design could be applied to disease therapies beyond diabetes

Trump again claims he’s bringing down drug prices, but details of how are skimpy

Higher dosage of opioids for outpatient knee surgery is linked to increased risk of overdose death

Study: COVID-19 vaccine should be at least 80% effective to prevent ongoing pandemic

Antibiotics used for treating COVID-19 patients may result in increased resistance to drugs' benefits

Delivering split immunotoxins separately to cancer cells can reduce life-threatening side effects

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Latest News